Tag: monoclonal antibody biosimilars

Monoclonal antibody biosimilars offer the same clinical benefits as original biologics at lower costs. Learn about approved examples like trastuzumab and rituximab biosimilars, their safety, uses in cancer and autoimmune diseases, and why adoption is growing.